Pharma Journalist 8947 posts 0 comments

The U.S. Food and Drug Administration has approved Recarbrio (imipenem, cilastatin and relebactam), an antibacterial drug product to treat adults with complicated urinary tract…
Read More...

Lonza has selected Rockwell Automation for the turnkey implementation of the Lonza strategic vision of bringing the digital factory to nine former Capsugel facilities that manufacture…
Read More...

Epistem Limited, the UK based pre-clinical and clinical research services company announces the expansion of its in vitro model portfolio by the completion of an agreement with Hubrecht…
Read More...

Novartis announced the US Food and Drug Administration (FDA) accepted the company's Biologics License Application (BLA) and has granted Priority Review for its investigational sickle…
Read More...

AM-Pharma B.V., a clinical stage biopharmaceutical company, leading in the development of a treatment for acute kidney injury (AKI) with its innovative recombinant human Alkaline…
Read More...

Kite, a Gilead Company (Nasdaq: GILD), announced plans for a new 67,000-square-foot facility in Oceanside, California, dedicated to the development and manufacturing of viral vectors, a…
Read More...

Sosei Group Corporation announces that it has entered into a multi-target research collaboration and license agreement with Genentech, a member of the Roche Group, to discover and…
Read More...

SMi Report: SMi interviewed Min Wei from AstraZeneca for the upcoming Wearable Injectors & Connected Devices 2019 conference SMi Group is proud to introduce some insightful…
Read More...

Dicerna Pharmaceuticals, Inc. announced that the U.S. Food and Drug Administration (FDA) has granted a Breakthrough Therapy Designation (BTD) to DCR-PHXC for the treatment of patients…
Read More...

AbbVie, a research-based global biopharmaceutical company, announced that it has acquired Seattle-based Mavupharma, a privately held biopharmaceutical company focused on novel…
Read More...